
Free Daily Podcast Summary
by Mohammed Paika
Welcome to the Dr. Paika Podcast — where medicine, fitness, and humanity come together. Hosted by Dr. Mohammed K. Paika, M.D., double board-certified in obesity & internal medicine with over two decades of hospital experience, this show dives deep into the science of health, obesity, longevity, and mindset — but with compassion, not complexity. From hospital medicine to the gym floor, from patient care to personal growth — every episode blends real clinical insight with practical, inspiring stories that help you live better and think deeper. 💡 Topics include: Obesity & metabolic health Longevity & fitness Nutrition & preventive medicine Doctor insights from 20+ years in hospitals across the US! Mindset, mental health, and motivation 🎧 Subscribe for weekly conversations that are honest, empowering, and rooted in science — all from a doctor who believes medicine should heal the mind and body.
The most recent episodes — sign up to get AI-powered summaries of each one.
#Ozempic #Wegovy #Zepbound #GLP1 #weightlossjourney Are you taking Wegovy, Ozempic, or Zepbound and feeling like your results have stalled? In this video, board-certified physician Dr. Mohammed Paika breaks down the 5 mistakes that quietly sabotage GLP-1 results — and exactly what to do instead to keep losing fat, protect your muscle, and avoid unnecessary side effects.Drawing on his experience as a hospitalist and obesity medicine specialist, Dr. Paika walks through dose titration, nutrition, digestion, and lab work — the pieces most people never get told about.TIMESTAMPS:0:00 Intro — Why Your Results Might Be Stalling0:53 Meet Dr. Paika1:37 Mistake #1: Chasing the Calendar Instead of Your Biology4:07 Mistake #2: Treating the Medication Like It Replaces the Basics6:02 Mistake #3: Eating Too Little (and Losing the Wrong Weight)8:29 Mistake #4: Ignoring What Your Gut Is Telling You10:47 Mistake #5: Never Checking Your Blood Work12:27 Final Thoughts + What to Watch NextREFERENCES:1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989-1002.2. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205-216.3. Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27:740-756.4. Taheri S, et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased BMI. PLoS Med. 2004;1(3):e62.5. Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006;84:475-482.6. Longland TM, et al. Higher dietary protein during an energy deficit promotes greater lean mass gain and fat loss. Am J Clin Nutr. 2016;103:738-746.7. Holst JJ. The physiology of glucagon-like peptide-1. Physiol Rev. 2007;87:1409-1439.8. Monami M, et al. Safety issues with GLP-1 receptor agonists (pancreatitis, pancreatic cancer, cholelithiasis). Diabetes Obes Metab. 2017;19(9):1233-1241.9. American Society of Anesthesiologists. Consensus-based guidance on preoperative management of patients on GLP-1 receptor agonists. 2023.10. Garvey WT, et al. AACE/ACE comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1-203.🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime AccessComprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.https://www.drmohammedpaika.com📩 FREE GLP-1 Diet Cookbook + Weekly NewsletterGet weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.https://www.drmohammedpaika.com/newsletter📚 The Weight Equation & The Physician’s PhysiquePhysician-written, evidence-based guides to obesity, weight loss, nutrition, metabolism, exercise, body composition & healthier living.https://www.drmohammedpaika.com/books👥 Metabolic Health Communityhttps://www.skool.com/metabolic-health-community-5316👨⚕️ ABOUT DR. MOHAMMED K. PAIKABoard-Certified in Internal Medicine and Obesity MedicineCertified Personal Trainer & Nutrition CoachHelping people understand metabolism, hormones, and sustainable health through evidence-based medicine.⚕️ MEDICAL & EDUCATIONAL DISCLAIMER: This content is for general educational and informational purposes only and is not medical advice or a substitute for care from your healthcare provider. Viewing this content does not create a doctor-patient relationship. Always consult a qualified healthcare professional before starting, stopping, or changing any medication, diet, exercise, or weight-loss plan. Individual results and risks vary. You assume responsibility for decisions made based on this content.
#GLP1 #Tirzepatide #Semaglutide #WeightLoss #ObesityMedicineShould you increase your GLP-1 dose — or actually decrease it? Before you touch that pen, run through the 7 checks I use with my own patients (and on myself) to decide whether it's time to go up, hold steady, or come down. This isn't about chasing the highest dose on the label — it's about finding the dose you can tolerate and sustain for the long run.I'm Dr. Mohammed Paika — internal medicine physician, board-certified in obesity medicine, and a GLP-1 user myself. In this video I walk through dose duration, your real weight trend, hunger and food noise, tolerability, plateaus vs. real stalls, the rest of your system (protein, sleep, training), and your actual goals — with real hospitalist cases on what happens when dosing goes wrong.🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime AccessComprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.https://www.drmohammedpaika.com📩 FREE GLP-1 Diet Cookbook + Weekly NewsletterGet weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.https://www.drmohammedpaika.com/newsletter📚 The Weight Equation & The Physician’s PhysiquePhysician-written, evidence-based guides to obesity, weight loss, nutrition, metabolism, exercise, body composition & healthier living.https://www.drmohammedpaika.com/books👥 Metabolic Health Communityhttps://www.skool.com/metabolic-health-community-5316👨⚕️ ABOUT DR. MOHAMMED K. PAIKABoard-Certified in Internal Medicine and Obesity MedicineCertified Personal Trainer & Nutrition CoachHelping people understand metabolism, hormones, and sustainable health through evidence-based medicine.TIMESTAMPS0:00 – Intro: should you change your GLP-1 dose?2:12 – How long have you been at this dose?4:00 – What does your real weight trend say?6:36 – Free GLP-1 Diet Cookbook7:13 – What's happening with your hunger?9:05 – How well are you tolerating this dose?11:17 – The GLP-1 Masterclass11:58 – Are you really at a plateau?13:23 – What else changed in your system?14:55 – What are you actually trying to achieve?16:45 – Physician safety reminder17:34 – What's nextReferencesZepbound (tirzepatide) injection, for subcutaneous use. Highlights of Prescribing Information. Eli Lilly and Company. pi.lilly.com/us/zepbound-uspi.pdf; U.S. Food and Drug Administration label, accessdata.fda.gov.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989-1002.Look M, Dunn JP, Kushner RF, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes Obes Metab. 2025. PMID: 39996356.Monami M, Nreu B, Scatena A, et al. Safety issues with GLP-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): data from randomized controlled trials. Diabetes Obes Metab. 2017;19(9):1233-1241.Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332:621-628.Hall KD. Predicting metabolic adaptation, body weight change, and energy intake in humans. Lancet Diabetes Endocrinol. 2014;2:395-406.Longland TM, Oikawa SY, Mitchell CJ, et al. Higher compared with lower dietary protein during an energy deficit combined with intense exercise promotes greater lean mass gain and fat mass loss. Am J Clin Nutr. 2016;103:738-746.Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength. Br J Sports Med. 2018;52:376-384.Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity. Am J Clin Nutr. 2025;122:344-367.Garvey WT, Mechanick JI, Brett EM, et al. AACE/ACE comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1-203.⚕️ MEDICAL & EDUCATIONAL DISCLAIMER: This content is for general educational and informational purposes only and is not medical advice or a substitute for care from your healthcare provider. Viewing this content does not create a doctor-patient relationship. Always consult a qualified healthcare professional before starting, stopping, or changing any medication, diet, exercise, or weight-loss plan. Individual results and risks vary. You assume responsibili
#BPC157 #PeptideTherapy #TendonHealing #RegenerativeMedicine #healthscience BPC-157 is everywhere right now — but does the evidence actually justify putting this peptide into your body? In this video, Dr. Mohammed Paika (board-certified internal medicine & obesity medicine) breaks down what BPC-157 actually does, what the animal research shows, what we really know about human safety, and the one theoretical risk that concerns him most as a physician.BPC-157 is not FDA-approved for any human use.🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime AccessComprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.https://www.drmohammedpaika.com📩 FREE GLP-1 Diet Cookbook + Weekly NewsletterGet weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.https://www.drmohammedpaika.com/newsletter📚 The Weight Equation & The Physician’s Physiquehttps://www.drmohammedpaika.com/books👥 Metabolic Health Communityhttps://www.skool.com/metabolic-health-community-5316Timestamps0:00 – Intro: Does the evidence justify this?0:44 – What BPC-157 Actually Is2:19 – How BPC-157 Works (The Mechanism)4:18 – The Musculoskeletal Evidence7:51 – Gut Health10:58 – Brain & Nervous System13:14 – Cardiovascular Health14:07 – The Honest Safety Picture16:20 – What Human Data We Actually Have19:24 – The Risk That Concerns Me Most (Cancer)21:46 – Who Should Actually Consider This24:26 – The Regulatory Reality (FDA, 2026)ReferencesStaresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon. J Orthop Res. 2003;21(6):976-983.Krivic A, et al. Achilles detachment in rat and BPC 157: tendon-to-bone healing. J Orthop Res. 2006;24(5):982-989.Cerovecki T, et al. Pentadecapeptide BPC 157 improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155-1161.Staresinic M, et al. Effective therapy of transected quadriceps muscle in rat: BPC 157. J Orthop Res. 2006;24(5):1109-1117.Novinscak T, et al. BPC 157 as effective therapy for muscle crush injury in the rat. Surg Today. 2008;38(8):716-725.Šebečić B, et al. Osteogenic effect of BPC-157 on segmental bone defect healing in rabbits. Bone. 1999;24(3):195-202.Duzel A, et al. BPC 157 in colitis and ischemia/reperfusion in rats. World J Gastroenterol. 2017;23(48):8465-8488.Vuksic T, et al. BPC 157 heals ileoileal anastomosis in the rat. Surg Today. 2007;37(9):768-777.Sikiric P, et al. BPC 157 effects on stomach mucosa integrity and blood pressure. Life Sci. 1994;54(5):PL63-68.Park JM, et al. BPC 157 rescued NSAID-cytotoxicity via intestinal permeability. Curr Pharm Des. 2020;26(25):2971-2981.Tudor M, et al. Traumatic brain injury in mice and BPC 157 effect. Regul Pept. 2010;160(1-3):26-32.Vukojević J, et al. BPC 157 in hippocampal ischemia/reperfusion injuries in rats. Brain Behav. 2020;10(8):e01726.Gjurasin M, et al. Peptide therapy with BPC 157 in traumatic nerve injury. Regul Pept. 2010;160(1-3):33-41.Perovic D, et al. BPC 157 improves healing course of spinal cord injury in rats. J Orthop Surg Res. 2019;14:199.Zemba Cilic A, et al. BPC 157 counteracts catalepsy in rat schizophrenia-like models. Behav Brain Res. 2021;396:112919.Sikiric P, et al. Antidepressant effect of BPC 157 in Porsolt's test and chronic stress in rats. J Physiol Paris. 2000;94(2):99-104.Xu C, et al. Preclinical safety evaluation of BPC-157. Regul Toxicol Pharmacol. 2020;114:104665.He W, et al. Pharmacokinetics of BPC-157 in rats and dogs. Front Pharmacol. 2022;13:1026182.Lee E, et al. Effect of BPC-157 on interstitial cystitis symptoms: a pilot study. Altern Ther Health Med. 2024;30:12-17.Lee E, Burgess C. Safety of IV infusion of BPC-157 in humans: a pilot study. Altern Ther Health Med. 2025.Lee E, Padgett B, et al. Intra-articular BPC 157 for knee pain. Altern Ther Health Med. 2021;27(S1).ClinicalTrials.gov. Study of BPC-157 in healthy volunteers. NCT02637284. Withdrawn.Nair AB, Jacob S. Dose conversion between animals and humans. J Basic Clin Pharm. 2016;7(2):27-31.U.S. FDA. Pharmacy Compounding Advisory Committee vote on BPC-157, July 23, 2026. See also: Pharmaceutical Executive, July 24, 2026.U.S. FDA. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks.⚕️ MEDICAL & EDUCATIONAL DISCLAIMER: This content is for general educational and informational purposes only and is not medical advice or a substitute for care from your healthcare provider. Viewing this content does not create a doctor-patient relationship. Always consult a qualified healthcare professional b
#GLP1 #Semaglutide #Tirzepatide #Inflammation #obesitymedicine GLP-1 drugs like semaglutide and tirzepatide don't just lower weight and blood sugar — the research increasingly shows they change inflammation too. In this video, Dr. Mohammed Paika (board-certified internal medicine + obesity medicine, hospitalist) breaks down what CRP actually measures, why chronic inflammation happens, how much of the anti-inflammatory effect is really just weight loss versus a separate biological pathway, and why tirzepatide's second receptor (GIP) may make it different from semaglutide.🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime AccessComprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.https://www.drmohammedpaika.com📩 FREE GLP-1 Diet Cookbook + Weekly NewsletterGet weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.https://www.drmohammedpaika.com/newsletter📚 The Weight Equation & The Physician’s PhysiquePhysician-written, evidence-based guides to obesity, weight loss, nutrition, metabolism, exercise, body composition & healthier living.https://www.drmohammedpaika.com/books👥 Metabolic Health Communityhttps://www.skool.com/metabolic-health-community-5316👨⚕️ ABOUT DR. MOHAMMED K. PAIKABoard-Certified in Internal Medicine and Obesity MedicineCertified Personal Trainer & Nutrition CoachHelping people understand metabolism, hormones, and sustainable health through evidence-based medicine.Timestamps0:00 Introducing the GLP-1 inflammation question1:03 Who I am and why I'm covering this2:54 What CRP actually measures on your labs5:19 What inflammation really is (the alarm system)7:35 Why visceral fat sounds a false alarm10:23 Free GLP-1 Diet Cookbook11:09 The puzzle: is it just weight loss?15:01 Where the independent anti-inflammatory signal comes from17:21 Why tirzepatide's GIP receptor might be different20:30 What this does NOT mean (important caution)21:34 Bringing it all together22:42 Closing thoughts + GLP-1 MasterclassReferencesWong CK, et al. Central GLP-1 receptor activation inhibits TLR agonist-induced inflammation. Cell Metab. 2024;36(1):130-143.e5.Ren Y, Chen Y. GLP-1 RAs and circulating inflammatory markers in T2D: meta-analysis. Diabetes Obes Metab. 2025.Semaglutide 2.4mg and CRP in STEP 1, 2, 3: exploratory analyses. eClinicalMedicine. 2023;55:101737.Semaglutide and hsCRP: SUSTAIN/PIONEER analyses. Cardiovasc Diabetol. 2022;21:184.Rodbard HW, et al. PIONEER 2 Trial. Diabetes Care. 2019;42(12):2272-2281.Semaglutide and hsCRP in SELECT: prespecified secondary analysis. PMID: 42610271.Anti-inflammatory effects of tirzepatide: meta-analysis. Rev Endocr Metab Disord. 2025.Sattar N, et al. Tirzepatide and hsCRP: SURPASS-4 post hoc. Circulation. 2023;148(suppl 1).Inflammatory biomarkers with tirzepatide: SURMOUNT-1/2 post hoc. Circulation. 2024;150(suppl 1).Wong CK, Drucker DJ. Anti-inflammatory actions of GLP-1-based therapies. J Clin Invest. 2025;135(21):e194751.'⚕️ MEDICAL & EDUCATIONAL DISCLAIMER: This content is for general educational and informational purposes only and is not medical advice or a substitute for care from your healthcare provider. Viewing this content does not create a doctor-patient relationship. Always consult a qualified healthcare professional before starting, stopping, or changing any medication, diet, exercise, or weight-loss plan. Individual results and risks vary. You assume responsibility for decisions made based on this content.
#Ozempic #Mounjaro #Semaglutide #Tirzepatide #GLP1 #WeightLoss #ObesityMedicine If you're on tirzepatide or semaglutide and the scale isn't moving the way you expected, this video is for you. I'm Dr. Mohammed Paika, board-certified in internal medicine and obesity medicine — I've been dealing with these medications in the hospital since they first came out, and I've managed my own weight through diet and training alone for over a decade. In this video I break down what tirzepatide and semaglutide actually are, why they were invented, how they work in your body, the exact dosing timeline, why the shot is only once a week, what you have to do around the medication for it to actually work, and what happens once you hit your goal weight. Most important is what to do besides taking the medication which is what my GLP-1 Masterclass is designed to teach you. 🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime AccessComprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.https://www.drmohammedpaika.com📩 FREE GLP-1 Diet Cookbook + Weekly NewsletterGet weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.https://www.drmohammedpaika.com/newsletter📚 The Weight Equation & The Physician’s PhysiquePhysician-written, evidence-based guides to obesity, weight loss, nutrition, metabolism, exercise, body composition & healthier living.https://www.drmohammedpaika.com/books👥 Metabolic Health Communityhttps://www.skool.com/metabolic-health-community-5316👨⚕️ ABOUT DR. MOHAMMED K. PAIKABoard-Certified in Internal Medicine and Obesity MedicineCertified Personal Trainer & Nutrition CoachHelping people understand metabolism, hormones, and sustainable health through evidence-based medicine.Timestamps0:00 Intro — Why These Drugs Weren't Built For Weight Loss1:39 My Story — Both Sides Of The Stethoscope3:16 Step 1 — Know What You're Actually Taking4:14 Step 2 — Know Why It Exists5:03 Step 3 — How It Works In Your Body (Trial Data & Patient Case)8:02 Where To Go Deeper (Masterclass & Free Cookbook)8:32 Step 4 — The Dose: Where You Start, Where You End Up9:57 Step 5 — Why It's Only Once A Week10:45 Step 6 — What You Have To Do Around The Medication12:59 Step 7 — What Happens When You Get There14:13 Closing ThoughtsReferencesWilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989–1002.Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387:205–216.Rubino D, et al. Effect of Continued Weekly Semaglutide vs Placebo on Weight Loss Maintenance. JAMA. 2021;325:1414–1425.FDA. ZEPBOUND (tirzepatide) Prescribing Information, label 217806.FDA. WEGOVY (semaglutide) Prescribing Information, label 215256.Paika M. GLP-1 Masterclass, Ch. 5 & 11 (drmohammedpaika.com).⚕️ MEDICAL & EDUCATIONAL DISCLAIMER: This content is for general educational and informational purposes only and is not medical advice or a substitute for care from your healthcare provider. Viewing this content does not create a doctor-patient relationship. Always consult a qualified healthcare professional before starting, stopping, or changing any medication, diet, exercise, or weight-loss plan. Individual results and risks vary. You assume responsibility for decisions made based on this content.
#Peptides #PeptideTherapy #GLP1 #AntiAgingMedicine #bpc157 Peptides didn't start with a wellness influencer — they started with a dying 14-year-old boy in 1922 and a shot of insulin. Today that same category includes everything from FDA-approved medications to unregulated research chemicals sold online with zero oversight.In this video I break down over 20 peptides — from BPC-157 and TB-500 to semaglutide, tirzepatide, retatrutide, and the newest FDA regulatory update on compounding access — organized into the three levels of biology they actually work on: cellular energy, tissue repair, and systemic control (your hormones, metabolism, and nervous system).🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime AccessComprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.https://www.drmohammedpaika.com📩 FREE GLP-1 Diet Cookbook + Weekly NewsletterGet weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.https://www.drmohammedpaika.com/newsletter📚 The Weight Equation & The Physician’s PhysiquePhysician-written, evidence-based guides to obesity, weight loss, nutrition, metabolism, exercise, body composition & healthier living.https://www.drmohammedpaika.com/books👥 Metabolic Health Communityhttps://www.skool.com/metabolic-health-community-5316TIMESTAMPS0:00 – Intro — why peptides aren't what you think1:21 – What a peptide actually is3:24 – Why "your body recognizes it" doesn't mean it's right for you5:15 – The three-layer framework6:18 – Layer One: Cellular energy (Epitalon, MOTS-c, SS-31)11:58 – Layer Two: Tissue repair (BPC-157, TB-500, GHK-Cu)18:08 – Layer Three: Hormones (Sermorelin, Ipamorelin, CJC-1295, Tesamorelin)21:36 – Layer Three: Metabolism (Semaglutide, Tirzepatide, Retatrutide)26:24 – Layer Three: Brain & nervous system (Semax, Selank, Dihexa, Cerebrolysin)31:40 – The most expensive mistake I see33:44 – What to do with thisReferencesWHO — Diabetes Fact Sheet: ~9 million people worldwide live with type 1 diabetes and require insulin injections for survivalNational Institute on Aging — "Exendin-4: From Lizard to Laboratory...and Beyond"PubMed — "The Development of Byetta (Exenatide) From the Venom of the Gila Monster" (PMID 21194543)Cell Metabolism (2015) — "The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance"Khavinson, Bondarev, Butyugov — "Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells," Bulletin of Experimental Biology and Medicine, 2003Khavinson et al. — "Effect of Epitalon on Biomarkers of Aging, Life Span and Spontaneous Tumor Incidence in Female Swiss-Derived SHR Mice," Bulletin of Experimental Biology and MedicineJohns Hopkins ICTR; Pharmacy Times; Drugs.com — FDA accelerated approval of Forzinity (elamipretide/SS-31) for Barth syndrome, September 19, 2025Genetics in Medicine — Phase 2/3 randomized trial of elamipretide (SS-31) in Barth syndrome (PMC7935714)Pickart et al. — "Regenerative and Protective Actions of the GHK-Cu Peptide in the Skin and Other Tissues" (PMC6073405)USADA — Athlete Advisory on 2022 WADA Prohibited List changes (BPC-157)Sport Integrity Australia — Thymosin Beta-4 (TB-500) substance profilePharmaceutical Executive — "FDA Votes to Loosen Restrictions for Four Peptides" (July 23, 2026); STAT News coverage of the same PCAC vote (BPC-157 8-6, TB-500 8-6, KPV 8-6, MOTS-c 7-5 — advisory only, formal rulemaking still pending)CBS News — "Stallone Pleads Guilty to Import Charge" / "Australia Fines Sly for Toting Hormones" (2007); Hollywood Reporter (2007); Taipei Times wire report (May 22, 2007)FDA — Approved labeling for EGRIFTA (tesamorelin for injection)Jastreboff et al., New England Journal of Medicine, 2023 — Phase 2 trial of retatrutidePharmaceutical Journal / AJMC / Pharmacy Times, May 2026 — TRIUMPH-1 topline results (Eli Lilly; peer review pending)Alzheimer's Drug Discovery Foundation, Cognitive Vitality — Dihexa peptide profileNeurologyLive / FierceBiotech — Fosgonimeton LIFT-AD (Nov 2024) and SHAPE (Dec 2023) trials, both missed primary endpointZiganshina LE et al., Cochrane Database of Systematic Reviews, 2020 — Cerebrolysin for acute ischaemic stroke⚕️ MEDICAL & EDUCATIONAL DISCLAIMER: This content is for general educational and informational purposes only and is not medical advice or a substitute for care from your healthcare provider. Viewing this content does not create a doctor-patient relationship. Always consult a qualified healthcare professional before starting, stopping, or changin
#Phentermine #WeightLoss #ObesityMedicine #GLP1 #weightlosstips The #1 mistake I see patients make on phentermine isn't a dosing error — it's that they stop eating. In this video, Dr. Mohammed Paika (board-certified in Internal Medicine and Obesity Medicine, 20 years as a hospitalist) breaks down exactly why appetite suppression gets confused with starvation, the real physiology of what happens to your metabolism and muscle when you under-eat on phentermine, a patient case from the hospital floor you won't forget, and the protein-first framework to actually keep the weight off long-term.You'll learn:– What phentermine actually does in your body (and why it's still the most-prescribed weight-loss medication in the U.S.)– The 3-stage physiology of "starvation mode" — and the real data behind it– A protein-first meal-timing framework you can start today– Why resistance training is non-negotiable for protecting your metabolism– Why phentermine isn't your only option — and how to know if it's the right one for you🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime AccessComprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.https://www.drmohammedpaika.com📩 FREE GLP-1 Diet Cookbook + Weekly NewsletterGet weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.https://www.drmohammedpaika.com/newsletter📚 The Weight Equation & The Physician’s PhysiquePhysician-written, evidence-based guides to obesity, weight loss, nutrition, metabolism, exercise, body composition & healthier living.https://www.drmohammedpaika.com/books👥 Metabolic Health Communityhttps://www.skool.com/metabolic-health-community-5316👨⚕️ ABOUT DR. MOHAMMED K. PAIKABoard-Certified in Internal Medicine and Obesity MedicineCertified Personal Trainer & Nutrition CoachHelping people understand metabolism, hormones, and sustainable health through evidence-based medicine.Timestamps0:00 Intro — The Mistake Almost Everyone Makes on Phentermine1:05 What Phentermine Actually Does In Your Body3:17 The Real Mistake: Not Eating4:21 Why It Feels Like Winning At First5:24 The 3 Stages of Starvation Mode9:28 Free Resource: The GLP-1 Diet Cookbook10:20 The Patient I'll Never Forget12:26 What To Eat Instead: The Protein-First Framework15:44 Protect Your Muscle & Metabolism17:56 Phentermine Isn't Your Only Option19:27 Playing The Long Game21:43 The Bottom Line + Free ResourcesReferencesU.S. FDA, Phentermine Hydrochloride prescribing information (Initial Approval 1959)Fothergill E, et al. Obesity. 2016;24(8):1612–1619Lewis KH, et al. Obesity. 2019;27(4):591–602Hunter GR, et al. Obesity. 2008;16(5):1045–1051Mifflin MD, et al. Am J Clin Nutr. 1990;51(2):241–247Wang Z, et al., organ metabolic rate research; Javed F, et al., body composition researchNBC Sports / Olympics.com / EssentiallySports — reporting on Michael Phelps's dietLewis KH, Gudzune KA, Ard JD. Current Obesity Reports. 2024;13(1):132–140⚕️ MEDICAL & EDUCATIONAL DISCLAIMER: This content is for general educational and informational purposes only and is not medical advice or a substitute for care from your healthcare provider. Viewing this content does not create a doctor-patient relationship. Always consult a qualified healthcare professional before starting, stopping, or changing any medication, diet, exercise, or weight-loss plan. Individual results and risks vary. You assume responsibility for decisions made based on this content.
#Zepbound #Wegovy #Tirzepatide #Semaglutide #glp1 Zepbound and Wegovy are the two most talked-about weight loss medications right now — but the headlines comparing them skip the context that actually matters. In this video, I break down how tirzepatide (Zepbound) and semaglutide (Wegovy) actually work in your body, compare the real clinical trial data — including the new SURMOUNT-5 head-to-head trial — and walk through the side effects, cost, and questions you need to bring to your physician before choosing between them.I'm Dr. Mohammed Paika — board-certified in Internal Medicine and Obesity Medicine, and a practicing hospitalist for over 15 years. I built DrMohammedPaika.com to give people real, evidence-based guidance on GLP-1 medications, nutrition, and exercise, because a prescription without a plan for your muscle, your nutrition, and your training is only half a treatment.🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime AccessComprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.https://www.drmohammedpaika.com📩 FREE GLP-1 Diet Cookbook + Weekly NewsletterGet weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.https://www.drmohammedpaika.com/newsletter📚 The Weight Equation & The Physician’s PhysiquePhysician-written, evidence-based guides to obesity, weight loss, nutrition, metabolism, exercise, body composition & healthier living.https://www.drmohammedpaika.com/books👥 Metabolic Health Communityhttps://www.skool.com/metabolic-health-community-5316👨⚕️ ABOUT DR. MOHAMMED K. PAIKABoard-Certified in Internal Medicine and Obesity MedicineCertified Personal Trainer & Nutrition CoachHelping people understand metabolism, hormones, and sustainable health through evidence-based medicine.Timestamps00:00 Introduction01:10 Who's Giving You This Information03:22 Wegovy vs. Zepbound: The Timeline04:52 How These Medications Actually Work07:28 Dosing and What's New in 202610:01 Side Effects (And a Case From My Hospital)13:11 Who Actually Qualifies14:09 The Individual Trial Data: STEP 1 vs. SURMOUNT-115:22 SURMOUNT-5: The Head-to-Head Trial17:28 Why the Average Doesn't Decide Your Case18:17 The Part Everyone Skips: Your Muscle20:16 What These Medications Cost in 202622:36 A Patient Case That Changed My Approach24:14 Questions to Ask Your Physician25:22 The Bottom Line26:26 Where to Go From HereReferences Aronne LJ, et al. SURMOUNT-5, N Engl J Med (2025); Eli Lilly official results announcement, investor.lilly.comBaggio LL, Drucker DJ. Biology of Incretins: GLP-1 and GIP. Gastroenterology. 2007;132(6):2131-2157U.S. FDA approval history: semaglutide (Ozempic) 2017; semaglutide (Wegovy) June 2021Samms RJ, Coskun T, et al. Trends Endocrinol Metab. 2020;31(6):410-421Coskun T, Sloop KW, et al. Mol Metab. 2018;18:3-14Wegovy (semaglutide) U.S. Prescribing Information, Novo NordiskZepbound (tirzepatide) U.S. Prescribing Information, Eli LillyFDA approval of oral semaglutide (Wegovy pill), OASIS-4 trial, 2025Wilding JPH, et al. STEP 1. N Engl J Med. 2021;384:989-1002Jastreboff AM, et al. SURMOUNT-1. N Engl J Med. 2022;387:205-216He L, et al. JAMA Intern Med. 2022 (DOI 10.1001/jamainternmed.2022.0338)Neeland IJ, et al. Diabetes Obes Metab. 2024 (DOI 10.1111/dom.15728)Prado CM, Phillips SM, et al. Lancet Diabetes Endocrinol. 2024 (DOI 10.1016/S2213-8587(24)00272-9)NovoCare.com, Wegovy Cost, Coverage & Savings Resources, 2026Eli Lilly investor announcement, LillyDirect Self Pay Journey Program pricing, 2026⚕️ MEDICAL & EDUCATIONAL DISCLAIMER: This content is for general educational and informational purposes only and is not medical advice or a substitute for care from your healthcare provider. Viewing this content does not create a doctor-patient relationship. Always consult a qualified healthcare professional before starting, stopping, or changing any medication, diet, exercise, or weight-loss plan. Individual results and risks vary. You assume responsibility for decisions made based on this content.
Welcome to the Dr. Paika Podcast — where medicine, fitness, and humanity come together. Hosted by Dr. Mohammed K. Paika, M.D., double board-certified in obesity & internal medicine with over two decades of hospital experience, this show dives deep into the science of health, obesity, longevity, and mindset — but with compassion, not complexity. From hospital medicine to the gym floor, from patient care to personal growth — every episode blends real clinical insight with practical, inspiring stories that help you live better and think deeper. 💡 Topics include: Obesity & metabolic health Longevity & fitness Nutrition & preventive medicine Doctor insights from 20+ years in hospitals across the US! Mindset, mental health, and motivation 🎧 Subscribe for weekly conversations that are honest, empowering, and rooted in science — all from a doctor who believes medicine should heal the mind and body.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from Dr. Paika Podcast in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of Dr. Paika Podcast as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Mohammed Paika.
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
Dr. Paika Podcast publishes every few days. Our AI generates a summary within hours of each new episode.
Dr. Paika Podcast covers topics including Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.